Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Mar-15 6:03 PM View:  | Allergan Plc (AGN) | 05-Mar-15 | Grant | 2,282 | -- | -- | 17% 13.09K to 15.37K | |
| 09-Mar-15 6:03 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Payment of Exercise | 333 | $295.70 | $98,468.10 | (2%) 15.37K to 15.04K | 51% |
| 13-May-14 5:22 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 1,692 | $197.05 | $333,409.00 | 15% 11.4K to 13.09K | (26%) |
| 27-Nov-13 5:10 PM View: | Allergan Plc (AGN) | 26-Nov-13 | Market Sale | 10,000 | $162.60 | $1,626,000.00 | (47%) 21.4K to 11.4K | 10% |
| 02-Oct-13 9:11 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 21,396 | -- | -- | (100%) 21.4K to 0 | |
| 03-Oct-13 4:28 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 21,396 | -- | -- | 100% 0 to 21.4K | |
| 02-Oct-13 9:11 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 20,379 | -- | -- | 91% 22.48K to 42.86K | |
| 02-Oct-13 9:11 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 21,462 | $144.00 | $3,090,530.00 | (50%) 42.86K to 21.4K | 83% |
| 24-Sep-13 4:47 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-13 | Payment of Exercise | 1,011 | $135.50 | $136,990.00 | (4%) 23.49K to 22.48K | 82% |
| 14-Aug-13 5:41 PM View: | Watson Pharmaceuticals Inc. (ACT) | 12-Aug-13 | Market Sale | 4,820 | $133.23 | $642,166.00 | (17%) 28.31K to 23.49K | 82% |
| 14-Mar-13 5:22 PM View: | Watson Pharmaceuticals Inc. (ACT) | 14-Mar-13 | Market Sale | 1,000 | $91.77 | $91,770.00 | (3%) 29.31K to 28.31K | 74% |
| 08-Mar-13 5:59 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 7,491 | -- | -- | 34% 21.82K to 29.31K | |
| 05-Mar-13 7:21 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-13 | Payment of Exercise | 1,880 | $85.54 | $160,815.00 | (8%) 23.7K to 21.82K | 72% |
| 02-Nov-12 12:39 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Oct-12 | Grant | 2,909 | -- | -- | 14% 20.79K to 23.7K | |
| 12-Mar-12 2:26 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Mar-12 | Grant | 9,475 | -- | -- | 84% 11.31K to 20.79K | |
| 28-Feb-12 12:22 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-12 | Payment of Exercise | 478 | $58.17 | $27,805.30 | (4%) 11.79K to 11.31K | 61% |
| 23-Sep-11 4:01 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-11 | Payment of Exercise | 632 | $70.04 | $44,265.30 | (5%) 12.43K to 11.79K | 68% |
| 04-Mar-11 4:37 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-11 | Grant | 5,852 | -- | -- | 89% 6.57K to 12.43K | |
| 26-Feb-10 4:22 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-10 | Grant | 2,673 | -- | -- | 69% 3.9K to 6.57K | |
| 22-Sep-09 4:42 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-09 | Grant | 3,900 | -- | -- | 100% 0 to 3.9K |